OraSure Technologies acquires Sherlock Biosciences
232.63MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US68554V1089
CUSIP
68554V108
Sector
Healthcare
Industry
Medical Instruments & Supplies
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
2.30
Book Value
5.28
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.42
Wall Street Target Price
4.67
EPS Estimate Current Year
-0.55
EPS Estimate Next Year
-0.20
EPS Estimate Current Quarter
-0.1223
EPS Estimate Next Quarter
-0.0977
Most Recent Quarter
-
Revenue TTM
161,626,000
Gross Profit TTM
68,759,000
EBITDA
-24,559,000
Profit Margin
-19.77%
Return On Assets TTM
-4.80%
Return On Equity TTM
-7.77%
Revenue Per Share TTM
2.165
Qtly Revenue Growth YOY
-44.70%
Diluted Eps TTM
-0.42
Qtly Earnings Growth YOY
29.60%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
1.4763
Price Book MRQ
0.5795
Enterprise Value Revenue
0
Enterprise Value EBITDA
2
17.92
11.21%286.44
2.68%142.41
1.36%122.54
0.84%16.45
0.61%255.30
0.42%513.34
0.15%178.32
0.02%86.15
-0.87%126.23
-0.53%OraSure Technologies acquires Sherlock Biosciences